EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Vitamin D in Parkinson’s Disease: Evidence from Serum Concentrations, Supplementation, and VDR Gene Polymorphisms

Jamir Pitton Rissardo iD, Ana Leticia Fornari Caprara iD

NeuroSci · 16.12.2025 · 6 (4) · 130

DOI: 10.3390/neurosci6040130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift NeuroSci, online erschienen am 16.12.2025. Verfasst von Jamir Pitton Rissardo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Cooper University Hospital, Camden, NJ 08103, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Vitamin D (VitD) has been implicated in neuroprotection, yet its role in Parkinson’s disease (PD) remains unclear. This systematic review and meta-analysis aimed to evaluate the association between VitD status, supplementation, and vitamin D receptor (VDR) gene polymorphisms with PD risk and outcomes. Methodology: Following PRISMA guidelines, we searched PubMed, Scopus, and Google Scholar through August 2025 for observational studies, clinical trials, and genetic association studies. Primary outcomes included serum VitD levels in PD versus healthy controls (HCs), prevalence of VitD insufficiency/deficiency, and effects of VitD supplementation on motor symptoms. Secondary outcomes assessed associations between VDR polymorphisms and PD susceptibility. Data were synthesized using random- and fixed-effects models, with heterogeneity and publication bias evaluated. PROSPERO (CRD420251133875).

Results

Sixty-three studies (n ≈ 10,700 participants) met inclusion criteria. PD patients exhibited significantly lower VitD levels (SMD = −0.46; 95% CI: −0.51 to −0.41) and higher odds of insufficiency (OR = 1.52) and deficiency (OR = 2.20) compared to HC. Cohort data suggested sufficient VitD may reduce PD risk (HR = 0.83). Supplementation yielded modest, non-significant improvements in motor outcomes. Among 20 genetic studies, FokI (rs2228570) was most consistently associated with PD, while other VDR SNPs showed variable or null associations.

Conclusions

VitD deficiency is common in PD and may influence disease risk and motor function. Current evidence indicates limited benefit of supplementation for motor outcomes, and genetic associations remain inconsistent.

Schlagwörter

Stichwörter der Autor:innen

Parkinson’s diseasegene polymorphismsusceptibilityvitamin Dvitamin D receptor

Autor:innen und Institutionen

  • Neurology Department, Cooper University Hospital, Camden, NJ 08103, USA.

ORCID-Profile: Jamir Pitton Rissardo, Ana Leticia Fornari Caprara

Zitieren

APA

Rissardo, J. P., & Caprara, A. L. F. (2025). The Role of Vitamin D in Parkinson’s Disease: Evidence from Serum Concentrations, Supplementation, and VDR Gene Polymorphisms. NeuroSci, 6(4), 130. https://doi.org/10.3390/neurosci6040130

Vancouver

Rissardo JP, Caprara ALF. The Role of Vitamin D in Parkinson’s Disease: Evidence from Serum Concentrations, Supplementation, and VDR Gene Polymorphisms. NeuroSci. 2025;6(4):130. doi:10.3390/neurosci6040130

BibTeX
@article{Rissardo2025,
  author = {Rissardo, Jamir Pitton and Caprara, Ana Leticia Fornari},
  title = {The Role of Vitamin D in Parkinson’s Disease: Evidence from Serum Concentrations, Supplementation, and VDR Gene Polymorphisms},
  journal = {NeuroSci},
  year = {2025},
  volume = {6},
  number = {4},
  pages = {130},
  doi = {10.3390/neurosci6040130}
}
Kostenlos starten →